![Brivaracetam versus Levetiracetam for Epilepsy: A Review of Comparative Clinical Safety - NCBI Bookshelf Brivaracetam versus Levetiracetam for Epilepsy: A Review of Comparative Clinical Safety - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-rc1322-lrg.png)
Brivaracetam versus Levetiracetam for Epilepsy: A Review of Comparative Clinical Safety - NCBI Bookshelf
![Adjunctive brivaracetam – A prospective audit of outcomes from an epilepsy clinic - Epilepsy & Behavior Adjunctive brivaracetam – A prospective audit of outcomes from an epilepsy clinic - Epilepsy & Behavior](https://www.epilepsybehavior.com/cms/asset/cc467268-b280-49fe-8ab5-a2ac0108efbe/gr1.jpg)
Adjunctive brivaracetam – A prospective audit of outcomes from an epilepsy clinic - Epilepsy & Behavior
![UCB Announces BRIVIACT® (Brivaracetam) now Approved by FDA to Treat Partial-onset (Focal) Seizures in Pediatric Epilepsy Patients - EpilepsyU UCB Announces BRIVIACT® (Brivaracetam) now Approved by FDA to Treat Partial-onset (Focal) Seizures in Pediatric Epilepsy Patients - EpilepsyU](https://epilepsyu.com/wp-content/uploads/2018/05/briviact-filmtablette-100mg-56-stueck-800x800.jpg)
UCB Announces BRIVIACT® (Brivaracetam) now Approved by FDA to Treat Partial-onset (Focal) Seizures in Pediatric Epilepsy Patients - EpilepsyU
![Intravenous Brivaracetam in the Management of Acute Seizures in the Hospital Setting: A Scoping Review - Kiwon Lee, Pavel Klein, Prashant Dongre, Eun Jung Choi, Denise H. Rhoney, 2022 Intravenous Brivaracetam in the Management of Acute Seizures in the Hospital Setting: A Scoping Review - Kiwon Lee, Pavel Klein, Prashant Dongre, Eun Jung Choi, Denise H. Rhoney, 2022](https://journals.sagepub.com/cms/10.1177/08850666211073598/asset/images/large/10.1177_08850666211073598-fig1.jpeg)
Intravenous Brivaracetam in the Management of Acute Seizures in the Hospital Setting: A Scoping Review - Kiwon Lee, Pavel Klein, Prashant Dongre, Eun Jung Choi, Denise H. Rhoney, 2022
![Pharmacokinetics and Metabolism of 14C-Brivaracetam, a Novel SV2A Ligand, in Healthy Subjects | Drug Metabolism & Disposition Pharmacokinetics and Metabolism of 14C-Brivaracetam, a Novel SV2A Ligand, in Healthy Subjects | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/36/1/36/F2.large.jpg)
Pharmacokinetics and Metabolism of 14C-Brivaracetam, a Novel SV2A Ligand, in Healthy Subjects | Drug Metabolism & Disposition
![Brivaracetam use, effectiveness, and clinical outcomes (n = 56 patients). | Download Scientific Diagram Brivaracetam use, effectiveness, and clinical outcomes (n = 56 patients). | Download Scientific Diagram](https://www.researchgate.net/publication/348911917/figure/tbl1/AS:1000084951007233@1615450241790/Brivaracetam-use-effectiveness-and-clinical-outcomes-n-56-patients.png)